Page last updated: 2024-08-17

dinitrofluorobenzene and Disease Exacerbation

dinitrofluorobenzene has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, Y; Sengoku, T; Takakura, S1
Hwang, ST; Sells, RE; Wu, X1
Hou, JF; Jin, Y; Qu, F; Wu, CS; Zhang, JL1

Other Studies

3 other study(ies) available for dinitrofluorobenzene and Disease Exacerbation

ArticleYear
Repeated topical application of glucocorticoids augments irritant chemical-triggered scratching in mice.
    Archives of dermatological research, 2010, Volume: 302, Issue:9

    Topics: Administration, Topical; Animals; Betamethasone Valerate; Dermatitis, Atopic; Dermatitis, Irritant; Dexamethasone; Dinitrofluorobenzene; Disease Models, Animal; Disease Progression; Ear, External; Glucocorticoids; Mice; Mice, Inbred BALB C; Phorbol Esters; Skin Irritancy Tests

2010
Upregulation of inflammatory cytokines and oncogenic signal pathways preceding tumor formation in a murine model of T-cell lymphoma in skin.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:8

    Topics: Adrenal Cortex Hormones; Animals; Apoptosis; Cell Line, Tumor; Cytokines; Dermatitis, Irritant; Dinitrofluorobenzene; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Irritants; Lymphoma, T-Cell; Macrophages; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Transplantation; Neutrophils; Signal Transduction; Skin Neoplasms; Tumor Microenvironment; Up-Regulation

2011
Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Dinitrofluorobenzene; Disease Progression; Diterpenes; Ear; Epoxy Compounds; Hypersensitivity, Delayed; Kidney; Male; Mice; Mice, Inbred BALB C; Phenanthrenes; Sphingolipids; Spleen; Tandem Mass Spectrometry; Treatment Outcome

2012